Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial

<strong>Background:</strong> In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting antiretroviral therapy (ART). This group also has the greatest risk of morbidity and mortality associated with immun...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Kityo, C, Szubert, A, Siika, A, Heydermann, R, Bwakura-Dangarembizi, M, Lugemwa, A, Mwaringa, S, Griffiths, A, Nkanya, I, Kabahenda, S, Wachira, S, Musoro, G, Rajapakse, C, Etyang, T, Abach, J, Spyer, M, Wavamunno, P, Nyondo-Mipanda, L, Chidziva, E, Nathoo, K, Klein, N, Hakim, J, Gibb, D, Walker, A, Pett, S
Định dạng:	Journal article
Được phát hành:	Public Library of Science 2018

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial

Những quyển sách tương tự